Literature DB >> 24084031

Insulin and leptin levels in obese patients with and without breast cancer.

Maria del Socorro Romero-Figueroa1, José de Jesús Garduño-García, Jesús Duarte-Mote, Guadalupe Matute-González, Angel Gómez-Villanueva, Jhony De la Cruz-Vargas.   

Abstract

BACKGROUND: Leptin has been associated with progression and poor survival in BC. Moreover, it is still controversial as to whether the effect of leptin depends only on its correlation with body mass index (BMI), or could be a direct role of adipokine in the development of BC. The aim of this study was to identify if there was a difference between serum leptin levels and insulin in obese patients with and without BC. PATIENTS AND METHODS: A cross-sectional study was made in 156 women, a group of 78 with obesity and BC and 78 with obesity without BC. When subjects agreed to participate, written informed consent was obtained from all subjects. Biochemical variables such as glucose, triglycerides, high-density and low-density lipoprotein, cholesterol, insulin, and leptin were measured and homeostasis model assessment (HOMA-IR) was calculated.
RESULTS: The age, number of parities, glucose, HOMA-IR, and leptin were significantly different at P < .05.
CONCLUSION: Serum leptin levels and leptin/BMI ratio were statistically significantly increased in patients with BC.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Insulin; Insulin resistance; Leptina; Obesity

Mesh:

Substances:

Year:  2013        PMID: 24084031     DOI: 10.1016/j.clbc.2013.08.001

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


  15 in total

Review 1.  Linking obesity-induced leptin-signaling pathways to common endocrine-related cancers in women.

Authors:  Eunice Nyasani; Iqbal Munir; Mia Perez; Kimberly Payne; Salma Khan
Journal:  Endocrine       Date:  2018-09-14       Impact factor: 3.633

2.  Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A.

Authors:  Suman K Samanta; Anuradha Sehrawat; Su-Hyeong Kim; Eun-Ryeong Hahm; Yongli Shuai; Ruchi Roy; Subrata K Pore; Krishna B Singh; Susan M Christner; Jan H Beumer; Nancy E Davidson; Shivendra V Singh
Journal:  J Natl Cancer Inst       Date:  2016-12-31       Impact factor: 13.506

Review 3.  Persistent organic pollutants and obesity: are they potential mechanisms for breast cancer promotion?

Authors:  Denise K Reaves; Erika Ginsburg; John J Bang; Jodie M Fleming
Journal:  Endocr Relat Cancer       Date:  2015-01-26       Impact factor: 5.678

4.  Adiponectin: A Predictor for Breast Cancer Survival?

Authors:  Hikmet Erhan Güven; Lütfi Doğan; Mehmet Ali Gülçelik; Neşe Ersöz Gülçelik
Journal:  Eur J Breast Health       Date:  2018-12-19

5.  Breast Cancer Cell Colonization of the Human Bone Marrow Adipose Tissue Niche.

Authors:  Zach S Templeton; Wen-Rong Lie; Weiqi Wang; Yael Rosenberg-Hasson; Rajiv V Alluri; John S Tamaresis; Michael H Bachmann; Kitty Lee; William J Maloney; Christopher H Contag; Bonnie L King
Journal:  Neoplasia       Date:  2015-12       Impact factor: 5.715

6.  The association between obesity related adipokines and risk of breast cancer: a meta-analysis.

Authors:  Yu Gui; Qinwen Pan; Xianchun Chen; Shuman Xu; Xiangdong Luo; Li Chen
Journal:  Oncotarget       Date:  2017-05-13

Review 7.  Signaling Pathways Induced by Leptin during Epithelial⁻Mesenchymal Transition in Breast Cancer.

Authors:  Monserrat Olea-Flores; Juan Carlos Juárez-Cruz; Miguel A Mendoza-Catalán; Teresita Padilla-Benavides; Napoleón Navarro-Tito
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

Review 8.  Association between serum leptin levels and breast cancer risk: An updated systematic review and meta-analysis.

Authors:  Hui Pan; Lin-Li Deng; Jia-Qi Cui; Lin Shi; Yi-Chun Yang; Jiang-Hui Luo; Dan Qin; Li Wang
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

9.  Associations between Diabetes and Quality of Life among Breast Cancer Survivors.

Authors:  Zheng Tang; Jiwei Wang; Hao Zhang; Li Sun; Furong Tang; Qinglong Deng; Jinming Yu
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

10.  Circulating Levels of Omentin, Leptin, VEGF, and HGF and Their Clinical Relevance with PSA Marker in Prostate Cancer.

Authors:  M Fryczkowski; R J Bułdak; T Hejmo; M Kukla; K Żwirska-Korczala
Journal:  Dis Markers       Date:  2018-08-16       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.